Evidence map›Paper›PMID 24801251›Full record

ReviewJournal of controlled release : official journal of the Controlled Release Society2014

Controlled release for local delivery of drugs: barriers and models.

Jennifer R Weiser, W Mark Saltzman

Abstract readReview
In one paragraph

Review in Journal of controlled release : official journal of the Controlled Release Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Transformative Materials for Interfacial Drug Delivery.Advanced healthcare materials · 2023
    Article
  12. Review
  13. Article
  14. Review
  15. Advanced Gene Therapy Strategies for the Repair of ACL Injuries.International journal of molecular sciences · 2022
    Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jennifer R WeiserDepartment of Biomedical Engineering, Yale University, New Haven, CT, 06511, USA. Electronic address: jennifer.weiser@yale.edu.
W Mark SaltzmanDepartment of Biomedical Engineering, Yale University, New Haven, CT, 06511, USA. Electronic address: mark.saltzman@yale.edu.

Funding

Molecular and Cellular Transport in MucusR01EB000487 · NIBIB · YALE UNIVERSITY · PI IWASAKI, AKIKO, SALTZMAN, W. MARK · 2002 to 2019
$5.0M
Yale Interdisciplinary Bioengineering Training Grant for Diabetes ResearchT32DK101019 · NIDDK · YALE UNIVERSITY · PI SALTZMAN, W. MARK · 2013 to 2017
$1.5M
NIBIB NIH HHS R01 EB000487NIDDK NIH HHS T32 DK101019
6 · The paper itself

Abstract

Controlled release systems are an effective means for local drug delivery. In local drug delivery, the major goal is to supply therapeutic levels of a drug agent at a physical site in the body for a prolonged period. A second goal is to reduce systemic toxicities, by avoiding the delivery of agents to non-target tissues remote from the site. Understanding the dynamics of drug transport in the vicinity of a local drug delivery device is helpful in achieving both of these goals. Here, we provide an overview of controlled release systems for local delivery and we review mathematical models of drug transport in tissue, which describe the local penetration of drugs into tissue and illustrate the factors - such as diffusion, convection, and elimination - that control drug dispersion and its ultimate fate. This review highlights the important role of controlled release science in development of reliable methods for local delivery, as well as the barriers to accomplishing effective delivery in the brain, blood vessels, mucosal epithelia, and the skin.

Indexed as

Drug Delivery SystemsModels, BiologicalBrainDelayed-Action PreparationsHumansModels, ChemicalSkin AbsorptionDelayed-Action PreparationsControlled releaseLocal deliveryPharmacokineticsPolymer systemsWound healing

Identifiers

PMID24801251
PMCPMC4142083

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.